News
CGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovations
Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, has established a Technology Advisory Board to provide independent, strategic guidance. The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies.